Status:

COMPLETED

Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus

Lead Sponsor:

Mayo Clinic

Conditions:

Diabetes Mellitus

Dyslipidemia

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Background- Statins are a safe and effective therapy to reduce cardiovascular risk in patients with type 2 diabetes; however some patients are not prescribed statins, others do not take it even after ...

Eligibility Criteria

Inclusion

  • Adult patients with type 2 diabetes attending a referral diabetes clinic, who are taking or not taking statins, and give consent to participate. Excluded were patients who had sensory or mental impairments or language barriers that preclude them from using the intervention and therefore participate in this trial.

Exclusion

    Key Trial Info

    Start Date :

    April 1 2005

    Trial Type :

    INTERVENTIONAL

    End Date :

    October 1 2005

    Estimated Enrollment :

    98 Patients enrolled

    Trial Details

    Trial ID

    NCT00217061

    Start Date

    April 1 2005

    End Date

    October 1 2005

    Last Update

    May 23 2011

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Mayo Clinic

    Rochester, Minnesota, United States, 55905

    Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus | DecenTrialz